Martin E. Duddy
Mindelsohn Way
Birmingham, ENG, United Kingdom
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.
Journal: Health technology assessment (Winchester, England)
Published: June 29, 2026
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.
Journal: Lancet (London, England)
Published: March 23, 2025
Brain reserve and physical disability in secondary progressive multiple sclerosis.
Journal: BMJ neurology open
Published: February 05, 2024
Patient selection and outcome of deep brain stimulation for multiple sclerosis-associated tremor.
Journal: British journal of neurosurgery
Published: November 08, 2023
Stick or twist? Cost-effectiveness of siponimod compared with continuing existing disease-modifying therapies in the treatment of active secondary progressive multiple sclerosis in the UK.
Journal: Journal of medical economics
Published: May 16, 2022
Delivering an advice and guidance service in neurology.
Journal: Practical neurology
Published: November 22, 2021
Early and unrestricted access to high-efficacy disease-modifying therapies: a consensus to optimize benefits for people living with multiple sclerosis.
Journal: Journal of neurology
Published: August 26, 2021
The impact of smoking cessation on multiple sclerosis disease progression.
Journal: Brain : a journal of neurology
Published: June 14, 2021
Results from SPECTRUM: A survey of healthcare professionals to understand current diagnosis and management practices for secondary progressive multiple sclerosis in the United Kingdom.
Journal: Multiple sclerosis and related disorders
Published: April 13, 2021
Transition to secondary progressive multiple sclerosis: The consequences for patients and healthcare systems, a healthcare professional survey.
Journal: Health science reports
Published: April 09, 2021
COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies.
Journal: Multiple sclerosis and related disorders
Published: March 06, 2021
Last Updated: 09/26/2026